HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ziwei Liu Selected Research

protoapigenone

4/2019The antagonism between apigenin and protoapigenone to the PDK-1 target in Macrothelypteris torresiana.
5/2014RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin.
7/2013A novel protoapigenone analog RY10-4 induces breast cancer MCF-7 cell death through autophagy via the Akt/mTOR pathway.
11/2012A new protoapigenone analog RY10-4 induces apoptosis and suppresses invasion through the PI3K/Akt pathway in human breast cancer.
6/2012RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1α and inhibition phosphorylation of AKT and mTOR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ziwei Liu Research Topics

Disease

10Neoplasms (Cancer)
01/2021 - 06/2012
4Inflammation (Inflammations)
09/2021 - 01/2016
3Prostatitis
10/2020 - 06/2019
3Breast Neoplasms (Breast Cancer)
05/2014 - 11/2012
2Insulin Resistance
01/2021 - 01/2016
2Carcinoma (Carcinomatosis)
01/2021 - 01/2020
2Pelvic Pain
10/2020 - 12/2019
2Infections
01/2020 - 01/2013
2Pain (Aches)
12/2019 - 06/2019
1Atherosclerosis
01/2022
1Major Depressive Disorder (Major Depressive Disorders)
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Glioma (Gliomas)
01/2021
1Heart Failure
01/2021
1Meningioma (Meningiomas)
01/2021
1Wounds and Injuries (Trauma)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
11/2020
1Hepatocellular Carcinoma (Hepatoma)
11/2020
1Necrosis
10/2020
1Thyroid Diseases (Thyroid Disease)
08/2020
1Bacterial Infections (Bacterial Infection)
04/2020
1Alopecia (Baldness)
02/2020
1Hashimoto Disease (Thyroiditis, Hashimoto)
02/2020
1Glomerulonephritis
02/2020
1Hyperparathyroidism
02/2020
1Autoimmune Polyendocrinopathies (Schmidt Syndrome)
02/2020
1Adult-Onset Still's Disease
02/2020
1Vasculitis (Vasculitides)
02/2020
1Myocardial Infarction
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Venous Thromboembolism
01/2020
1Opportunistic Infections (Opportunistic Infection)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
11/2019
1Gastroenteritis
01/2019
1Pathologic Processes
12/2018
1Type 2 Diabetes Mellitus (MODY)
01/2016
1Birth Weight (Birth Weights)
02/2015
1Fetal Macrosomia
02/2015
1Neoplasm Metastasis (Metastasis)
05/2014
1Prostatic Neoplasms (Prostate Cancer)
07/2009

Drug/Important Bio-Agent (IBA)

5protoapigenoneIBA
04/2019 - 06/2012
42- (1- hydroxy- 4- oxocyclohexa- 2,5- dienyl)pyran- 4- oneIBA
05/2014 - 06/2012
3Peptides (Polypeptides)IBA
10/2020 - 06/2019
2Messenger RNA (mRNA)IBA
09/2021 - 02/2015
2RNA (Ribonucleic Acid)IBA
09/2021 - 11/2020
2EnzymesIBA
10/2020 - 12/2018
2Eosine Yellowish-(YS) (Eosin)IBA
10/2020 - 06/2019
2Proteins (Proteins, Gene)FDA Link
11/2019 - 01/2019
1CholesterolIBA
01/2022
1RicinIBA
09/2021
1MicroRNAs (MicroRNA)IBA
09/2021
1SodiumIBA
01/2021
1Transfer RNA (tRNA)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Triglycerides (Triacylglycerol)IBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1GalactosidasesIBA
11/2020
1Long Noncoding RNAIBA
11/2020
1LuciferasesIBA
11/2020
1ImmunosorbentsIBA
10/2020
1Therapeutic UsesIBA
10/2020
1AntibodiesIBA
08/2020
1Pharmaceutical PreparationsIBA
04/2020
1Thyroxine (Levothyroxine)FDA LinkGeneric
02/2020
1AutoantibodiesIBA
02/2020
1CalciumIBA
02/2020
1Calcium Carbonate (Limestone)FDA Link
02/2020
1Cholecalciferol (Vitamin D3)FDA Link
02/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2020
1MethylprednisoloneFDA LinkGeneric
02/2020
1Hemoglobins (Hemoglobin)IBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1GlucocorticoidsIBA
01/2020
1Saline SolutionIBA
12/2019
1AntigensIBA
12/2019
1SolutionsIBA
12/2019
1Protein Disulfide-IsomerasesIBA
11/2019
1Hematoxylin (Haematoxylon)IBA
06/2019
1AutoantigensIBA
06/2019
1ApigeninIBA
04/2019
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2017
1Small Interfering RNA (siRNA)IBA
01/2017
1HMGB1 Protein (HMG1)IBA
01/2016
1Insulin-Like Growth Factor I (IGF-1)IBA
02/2015
1Insulin-Like PeptidesIBA
02/2015
1CateninsIBA
05/2014
1Cadherins (E-Cadherin)IBA
05/2014
1matrigelIBA
05/2014
1FlavonoidsIBA
07/2013
1Ammonium CompoundsIBA
01/2013
1Hydroxyl RadicalIBA
01/2013
1HydroquinonesIBA
06/2012

Therapy/Procedure

4Therapeutics
02/2020 - 12/2015
2Induction Chemotherapy
01/2021 - 01/2020
1Surgical Instruments (Clip)
01/2021
1Ligation
01/2020
1Intravenous Injections
01/2020
1Immunotherapy
01/2020
1Cesarean Section (Caesarean Section)
01/2020